Micropos Medical AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 0.207 million compared to SEK 0.231 million a year ago. Revenue was SEK 0.424 million compared to SEK 0.365 million a year ago. Net loss was SEK 5.3 million compared to SEK 4.06 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.03 a year ago.
For the nine months, sales was SEK 1.18 million compared to SEK 0.833 million a year ago. Revenue was SEK 2.92 million compared to SEK 1.3 million a year ago. Net loss was SEK 17.8 million compared to SEK 13.62 million a year ago. Basic loss per share from continuing operations was SEK 0.13 compared to SEK 0.11 a year ago.